Search

everythinglearnresearchcommunity

for

Search:↓

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

New therapies show promise for wound healing, but more research is needed for safe, affordable options.

Fungal infections are the most common skin issue in the region.

Antibody treatments show promise for hair loss but need more research.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

SLE and DM can coexist but are rare and need careful evaluation.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Brazilian patients with inflammatory bowel disease have a high rate of skin problems compared to healthy people.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

A man with severe leprosy developed painless ulcers and numbness, treated successfully with multiple drugs and vitamins.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

Patients often experience long-lasting changes to their hair after stem cell transplants.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.